chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt reported a seizure that occurred AM of 9/12/04, had been drinking alcohol, unknown quantitiy. Stayed night in a hotel, unknown duration of seizure.
Seven hours after receiving the second dose of the vaccine I experienced two hours of mild nausea, mild dizziness, and mild jaw soreness.
Hospitalized 01/30/2022; COVID-19 positive 01/30/2022; fully vaccinated plus booster  Discharge Provider: private* Primary Care Provider:  DO Admission Date: 1/30/2022 Discharge Date: Jan 31, 2022 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Generalized weakness [R53.1] Elevated troponin [R77.8] COVID-19 [U07.1]   HOSPITAL COURSE:   Patient is a 90 y.o. male with h/o intermittent A-Fib, HTN, HLD, CKD, COPD (on 2L via NC nocturnally), GERD, BPH and prior bladder and skin cancer, presenting to the ER on 1/30 with increasing weakness over the past 3 weeks.   In the ER, he was afebrile (Tmax 37.2), normotensive to borderline soft, transiently tachycardic, mildly tachypnic, and maintaining SpO2 in low to mid 90?s on baseline RA.  Initial labs are notable for stable renal dysfunction, hypomagnesemia, elevated trops with negative delta, normocytic anemia.  COVID screen is positive without concurrent influenza or RSV positivity.  UA is unremarkable.  EKG initially showed A-Flutter with RVR and non-specific ST-T change, but repeat study shows conversion to NSR with PVC?s.  CXR shows no acute process.  CTH shows no acute intracranial process, with note of probable microvascular ischemia and/or periventricular edema and disproportionate mild-to-moderate central volume loss and/or chronic NPH.  He was treated with IV mag sulfate. On admission MRI of brain, ultrasound carotids, echocardiogram, PT and OT were ordered.  MRI of brain was negative for acute stroke senescent findings with probable central involution though NPH is not excluded.  Echocardiogram showed EF of 48% and wall motion abnormalities.  Ultrasound was negative for significant carotid stenosis.  These results were discussed with patient as well as his daughter at bedside. PT and OT recommended home health.  Daughter and patient deferred home health. Patient and daughter also deferred  inpatient cardiology workup and preferred outpatient follow-up.
Rt eye twitching to left upper lip twitching. Fatigue, achey.
Pt developed hives 1 day later on inner elbows of both arms.  They are currently fading.  Pt did not seek medical tx & took no medications.
Arm swollen and red, initially 3x3 inch circle.  Entire body aches and pains.  Fever. Symptoms lasted until 12/08/2014 6:00 AM. Arm swelling continued to worsen to 6X7 inch area by 12/08.2014 21:00 PM.
Rash all over torso;  eyelids and under eyes are swollen and puffy
HIVES AND ITCHING ALL OVER HIS BODY. PT WENT TO EMERGENCY ROOM AS A RESULT
COVID Vaccine Breakthrough Case. Moderna Dose 1 10/29/21 (005C21A) and COVID Positive 11/8/21. 11/8/21: HPI is limited by patient's altered mental status. Collateral source of information is the medical record. Patient is a 92-year-old male who presented to the emergency department today with reported altered mental status. He was confused, agitated, and combative on arrival. The patient's son reported that he has had a progressive decline over the last 6 months, but this behavioral change was more acute. He was recently diagnosed with sundowners. On my this in the ED, the patient tells me the year is 1912. He is able to tell me his name. Tells me he lives alone and has a nurse that comes in. Cannot tell me who the president is. Not aggressive/combative at this time. He denies chest pain, shortness of breath, nausea, vomiting, diarrhea, abdominal pain, fever, and chills. On arrival to the ED, the patient's vitals were stable. He is 98% SpO2 on room air. His labs were fairly unremarkable. He has a troponin of 0.04, TSH 7.34, Free T4 0.84, hemoglobin 13.2. His urine was positive for large amount of leukoesterase. His COVID screening was positive. CXR showed no acute findings. CT of the head showed no acute intracranial findings, but did show severe parenchymal volume loss and white matter changes suggestive of advanced chronic microvascular ischemia. EKG showed AFib at a controlled rate. This appears to be chronic for the patient. The patient received 1g of Rocephin in the ED. 11/18/21: Patient is resting comfortably in bed. Has been unresponsive most of the day.  Awaiting hospice placement. Later deceased.
Severe pain at site and heaviness of arm.  Pain up to shoulder.  Fingers got cold for a short time.  Pain was severe enough that she was seen in clinic.  Also saw physician.  Diagnosis: Reaction to PPD.
This spontaneous report was received from a registered pharmacist refers to a patient of unknown age. On 04-FEB-2012, the patient was vaccinated with an expired vaccine dose of 0.65 ml ZOSTAVAX, (lot number reported as (672608/1715AA), expiry date 02-FEB-2013, route subcutaneous). No concomitant medications were reported. No adverse effect reported. Additional information has been requested.
shingles; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a male patient of an unknown age. No information was provided regarding medical history, concurrent conditions, or concomitant medications.   On or about 09-OCT-2013, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (lot#, expiration date, dose, dose# and route not specified) for the long-term prevention of shingles and zoster-related conditions. At the time of patient's vaccination, patient relied on the warning label affixed to zoster vaccine live (ZOSTAVAX), and the information relayed through patient's healthcare provider that zoster vaccine live (ZOSTAVAX) was effective in preventing shingles on a permanent basis and did not carry any significant risk of adverse effects, which induced patient to be vaccinated.  On an unspecified date, the patient experienced shingles. On an unspecified date, the patient was treated for shingles. And on an unknown date the patient was hospitalized.   As a direct and proximate result of patient's use of the zoster vaccine live (ZOSTAVAX) vaccine, patient has and would continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and will continue to suffer such losses, and damages in the future.   The outcome of the event of shingles was not reported. The reporter considered the event to be related to zoster vaccine live (ZOSTAVAX).
Pt was administered FLUVIRIN lot 111770P1 Exp 2/28/11 0.5ml IM on L deltoid and immediately after administration started to bruise.
My arm hurt at the muscle, had dead arm but it usually does. The spot was itchy and that was new. This time weeks after, I still have a discolored circle on my shoulder and my muscle hurts where the shot was injected. My arm is also weaker.  I?m not sure which flu shot.
The morning after vaccination, I came down with a fever of 100-101 F. This fever stayed with me for approx. the next 3 days. On June 2nd, while I was still somewhat having my fever, I began to break out in hives/welts all over my body. They would appear on a few areas of my body at a time, and then would go away and appear elsewhere. I presumed this was just a temporary auto-immune response, however, for the next 2-3 weeks, they would persist, all day, at varying points of the day. They itched and burned. Some were just red patches on my skin, while some had little bumps as well, and some even appeared as long thick white welts. I could scratch myself first as well, and then it would immediately appear. However, usually I did not even touch myself and they would appear. I began taking Benadryl at night to help me sleep, and although it gave a little relief, the results were always very temporary and the next morning they would be back.
Information has been received from a registered nurse referring to an unknown number of patients of unknown age and gender. On unknown dates these patients were vaccinated with improperly stored M-M-R II (dose, route and lot# were not reported). No adverse effects were reported. This is one of several cases reported by the same reporter. Additional information is not expected because the reporter would not like to be contacted.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 54-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 26Mar2021 at 12:00 as dose 1, single (Lot number: EN6207), in left arm, on 16Apr2021 at 12:00 as dose 2, single (Lot number: EW0169), in left arm, on 20Oct2021 at 12:00 as dose 3 (booster), single (Lot number: FE3590), in left arm and on 31Mar2022 at 12:00 as dose 4 (booster), single (Lot number: FJ9943) at the age of 53 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Breast cancer" (unspecified if ongoing); "melanoma" (unspecified if ongoing). There were no concomitant medications. Past drug history included: Erythromycin, reaction(s): "Known allergies: Erythromycin". The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (May2022) Negative, notes: 1 week after testing negative on PCR; (May2022) Positive, notes: Tested positive again (rapid) on 5th day; (unspecified date) Unknown results; (May2022) Positive, notes: tested positive again. Therapeutic measures were taken as a result of vaccination failure, covid-19.
This is a spontaneous report from a contactable consumer via Pfizer-sponsored program. The patient of an unspecified age and gender received BNT162B2 (PFIZER COVID-19 VACCINE, Lot number: unknown) via an unspecified route of administration as a SINGLE DOSE on an unknown date, for COVID-19 immunization. Medical history and concomitant medications were not reported. On an unspecified date, the patient underwent an antibody test, and it came back negative. The outcome of the event of antibody test came back negative was not reported. No follow up attempts are possible. Information about Lot/batch number cannot be obtained.
This spontaneous report as received from a other health professional refers to a female patient of unknown age. The patient was vaccinated with MMR II. No other co-suspects were reported. No concomitant medications were reported. On an unknown date the patient experienced expired vaccine used. No treatment information was reported. The outcome of expired vaccine used is unknown. Expired vaccine used is not related to MMR II. Lot # 1250Z Exp 09/29/2012. No adverse effects reported. No other information was provided. Additional information is not expected.
Child woke today with low grade fever 100 degrees and red/raised rash on her truck (back, shoulder blades, abd).  Rash is itchy.  Mom treating with TYLENOL, BENADRYL and Oatmeal Bath.  Hx of allergy to PENICILLIN - BACTRIN.
fever of 101, Chills, Headache, Nausea; symptoms lasted less than 12 hours; no medication taken; symptoms resolved overnight
Information has been received from a nurse practitioner and the mother concerning a 16 year old female with no medical history and drug allergies who on 28-JAN-2009 11:45 was vaccinated with the first 0.5 ml dose of GARDASIL (lot # 661703/0651X) IM in the left arm. On the same day the patient was also vaccinated with a dose of HAVRIX into the right arm. There was no other concomitant medication. About an hour later after the patient went to school she blanked out in class. This was after 12:30. The teacher thought the patient was sleeping because her head was down and he called her name. The kids in class shook her and she woke up. She lost consciousness for about 5 minutes. The patient said that she did not hear any of the lessons. The patient was recovered after she was shaken on the same day. The patient sought unspecified medical attention. This is one of several reports received from the same source. Additional information has been requested.
The patient developed numerous small itchy lesions all over. The lesion on the left thigh at the site of the injection has a 3 cm erythema and induration. Per RN, lesion occurred at site of varivax with other varicella appearing lesions on child's body; not a reaction to Prevnar.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 64-year-old male patient received BNT162b2 (BNT162B2), on 02Mar2021 as dose 1, single (Lot number: En6205), in left arm and on 30Mar2021 as dose 2, single (Lot number: Er8730) at the age of 62 years, in left arm for covid-19 immunisation; coviD-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE), on 27Oct2021 as dose number unknown, single (Lot number: 076c21a), in left arm and on 01Apr2022 as dose number unknown, single (Lot number: 002m21a), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Known allergies: Some fresh fruits" (unspecified if ongoing). Other medication in 2 weeks/Concomitant medication(s) included: ATORVASTATIN, stop date: 12Jul2022. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Unknown results; (19Jul2022) Negative, notes: Covid rebound symptoms 4 days after final Paxlovid dose and positive test result 5 days after final Paxlovid dose. Had tested negative 2 days after final Paxlovid dose; (22Jul2022) Positive, notes: Covid rebound symptoms 4 days after final Paxlovid dose and positive test result 5 days after final Paxlovid dose. Had tested negative 2 days after final Paxlovid dose. Therapeutic measures were taken as a result of vaccination failure, covid-19. The patient received Anti-viral details: COVID 19 Treatment, brand=Paxlovid, started on 12Jul2022 and stopped on 17Jul2022.
antibody titer for Hep A did not worked; This non-serious case was reported by a nurse via call center representative and described the occurrence of hepatitis a antibody negative in a 66-year-old male patient who received HAB (Twinrix adult) for prophylaxis.   Co-suspect products included HAB (Twinrix adult) for prophylaxis and HAB (Twinrix adult) for prophylaxis.   On 26-SEP-2023, the patient received the 3rd dose of Twinrix adult. On 20-APR-2023, the patient received the 2nd dose of Twinrix adult. On 20-MAR-2023, the patient received the 1st dose of Twinrix adult. On an unknown date, more than a month after receiving Twinrix adult, more than 6 months after receiving Twinrix adult and between 7 and 8 months after receiving Twinrix adult, the patient experienced hepatitis a antibody negative (Verbatim: antibody titer for Hep A did not worked). The outcome of the hepatitis a antibody negative was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 07-NOV-2023 The registered nurse called to inquire that at 12 months, can we give the Hep A or how to proceed. The registered nurse reported a patient received the first, second and third dose of Twinrix. and stated that they ran labs and the antibody titer measures showed Hepatitis B worked and the Hep A did not. The reporter did not consent to follow-up.
Patient received third/booster dose 3, BNT162b2; Pain at injection site; Chills during evening; Under arm lymph nodes inflammation; Severe body pain; Stiffness; Joint pain; Muscle spasms; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received third booster dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 33038RD) via an unspecified route of administration in the left arm on 13Nov2021 at 09:30 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included hypertension, atherosclerosis and endometriosis. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient received other vaccine influenza vaccine (MANUFACTURER UNKNOWN) on18Oct2021 for immunisation. Concomitant medications included atorvastatin calcium (ATORVASTIN), ethinylestradiol/ etonogestrel (NUVARING), fexofenadine hydrochloride (ALLEGRA) and ibuprofen (ADVIL); all for unknown indication from an unknown date and unknown if ongoing. The patient previously received amoxicillin/clavulanic acid (AUGMENTIN) for unknown indication on an unknown date and experienced drug allergy. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the left arm on 19Mar2021 at 16:00 (at the age of 41-years-old) and also received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the right arm on 10Apr2021 at 16:00 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. On an unknown date in Nov2021, at 03:00 the patient experienced pain at injection site, chills during evening, under arm lymph nodes inflammation, severe body pain and stiffness, joint pain and muscle spasms. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events pain at injection site, chills during evening, under arm lymph nodes inflammation, severe body pain and stiffness, joint pain and muscle spasms were not resolved at the time of this report.
Erythematous rash (Appears like a full body sunburn, slightly itchy, muscle achy and slight sore throat.
On April 5 around 3:30PM, I awoke from a nap and felt like a fullness in my left ear. That?s the first symptom that I noticed. Initially I thought it was congestion maybe from a possible cold coming on and I took Sudafed incase it was congestion. The next day, I didn?t notice any improve on April 6, 2021. The following day after that April 7, I did not hear someone talking directly to me on the left side and I realized I lost my hearing in the left ear. I immediately called Doctor and talked with him regarding the symptoms. And he scheduled me for an audiogram and an in person appointment for April 8. On April 8, I had an audiogram which showed profound hearing loss in my left ear. When Doctor  examined me, he said the treatment would be a period of high dose steroids 60mg per day for 14 days and a taper off. It would also include a series of intratympanic injections into the ear drum, one of which he did that day. That would be followed with 2 more injections, each a week apart. A total of three intratympanic injections. I began taking the high dose steroids and before each of the injections, I would have another audiogram to determine if my hearing got any better. And then I would be seen by Doctor  following the audiogram. No improvement in the hearing and continued to be a profound loss of hearing. The symptoms with the sudden hearing loss mimic the signs and symptoms of an acoustic neuroma. So at that first appointment, he also ordered an MRI of the brain. It did not show any tumor on the acoustic nerve so that ruled that out. April 10 was the date of the MRI. After the those treatments and no improvement in the hearing, possibly a month later, I was desperate to get any hearing back. There was a vitamin Doctor  recommended, and I ordered it. It was basically a vitamin supplement that?s supposed to reduce tinnitus. Since that time, I?ve just continued to have profound hearing loss on the left, tinnitus. I just had another audiogram yesterday and did not show any improvement and I didn?t have a chance to do a follow up yet with Doctor . The audiologist said I might be a candidate for some kind of hearing aid. I have my next appointment with Doctor on 01/26/2022. The struggle is, I?ve also been consulting my PCP because I?ve been concerned about the booster. PCP recommended not to get the booster at this time because the risk is too high. When I see Doctor , I?m going to see if I can get a possible exemption for my work. The reason for the last audiogram was because I thought my hearing was getting worse. It's an increasingly harder time hearing at work and hearing all the time in general.
After the 3rd dose I had a Macular hole on my right eye. I was given eye drops to see if it will help heal. I'm currently waiting for surgery to fix it
Vaccine administered without incident. Following administration patient began to feel week and nauseous. Patient was observed in vaccination area for approximately 5 minutes.  Patient was feeling better and was moved to post vaccination observation area. A few minutes later patient vomited.  Patient was cared for and after a few more minutes stated he was feeling much better.  Patient was observed longer and left without further incident.
Patient received 3rd dose in a 2-dose series of Zoster (Shingrix) vaccine because patient's chart was not up to date. No adverse effects were reported by patient.
Patient's mother called us on 5/28 to inform us that her daughter received the Pfizer vaccine on 5/16 and started having symptoms on 5/22: Swelling of lymph nodes, breasts, and what felt like her throat, a fever of 102F and felt like her heart was pounding. Patient's mother states that her heart is no longer pounding but is still having swelling and fever.
Pt is currently hospitalized and was admitted on 07/06/2021 due to COVID-19. Updated pt symptoms and pre-existing medical conditions. Pt has a PMH of arthritis, DM, GERD, HLD, and HTN. Pt complained of chills, aches, and pains, constipation, shortness of breath, and dry cough. Per medical records, patient developed rapid worsening hypoxia despite BiPAP support and was intubated on 07/13/2021 and proned. Patient died.
Information has been received from a registered nurse concerning two "geriatric males" with "cardiac conditions" who on 10-OCT-2006 (also reported as 11-OCT-2006) were vaccinated with PNEUMOVAX (lot number 650541/1004P).  On 11-OCT-2006 the patients experienced local adverse reactions, including pain, redness, "fever" in the arm, tenderness and swelling near the injection site.  The patient's sought unspecified medical attention.  The patients' local adverse reaction, pain, redness, "fever" in the arm, tenderness and swelling near the injection site persisted.  The records of testing prior to release of the lot in question have been rechecked and found to be satisfactory.  The lot met the requirements and was released.  Attempts are being made to obtain additional identifying information to distinguish the individual patients mentioned in this report.  Additional information will be provided if available.  Additional information has been requested.